Prognostic value of the proliferation marker Ki-67 in laryngeal carcinoma: Results of the Accelerated Radiotherapy with Carbogen Breathing and Nicotinamide phase III randomized trial

Saskia E. Rademakers, Ilse J. Hoogsteen, Paul F. Rijken, Chris H. Terhaard, Patricia A. Doornaert, Johannes A. Langendijk, Piet van den Ende, Albert J. van der Kogel, Johan Bussink, Johannes H. Kaanders

Research output: Contribution to journalArticleAcademicpeer-review

4 Citations (Scopus)
Original languageEnglish
Pages (from-to)171-176
JournalHead and Neck-Journal for the Sciences and Specialties of the Head and Neck
Volume37
Issue number2
DOIs
Publication statusPublished - Feb 2015

Keywords

  • hypoxia
  • radiotherapy
  • laryngeal carcinoma
  • proliferation
  • prognostic

Cite this

Rademakers, S. E., Hoogsteen, I. J., Rijken, P. F., Terhaard, C. H., Doornaert, P. A., Langendijk, J. A., van den Ende, P., van der Kogel, A. J., Bussink, J., & Kaanders, J. H. (2015). Prognostic value of the proliferation marker Ki-67 in laryngeal carcinoma: Results of the Accelerated Radiotherapy with Carbogen Breathing and Nicotinamide phase III randomized trial. Head and Neck-Journal for the Sciences and Specialties of the Head and Neck, 37(2), 171-176. https://doi.org/10.1002/hed.23569